title: Response to citalopram is not associated with SLC6A4 genotype in African-Americans and Caucasians with major depression.
abstract: OBJECTIVE
  Ethnic differences in genotype frequency provide a natural condition for assessing the contribution of gene variations to the causes and treatments of disease. Accordingly, the purpose of this study was to determine whether ethnic variations in allele frequencies of the serotonin transporter gene-linked polymorphic region (5-HTTLPR) of the SLC6A4 gene were related to the response to the treatment of depression.
  
  
  METHODS
  African-Americans (n=101) and Caucasians (n=100) with major depressive disorder were treated with the antidepressant citalopram (20-60mg/day) for 8weeks. Genotyping for the long (L) and short (s) alleles (LL, Ls, and ss) of the SLC6A4 gene was performed and the association between genotype and treatment response was assessed.
  
  
  RESULTS
  Subjects in both ethnic groups showed a significant reduction in depression scores over time (p<.0001). However, in spite of a significantly greater frequency of the L allele in African-Americans as compared to Caucasians, a comparable clinical response between the two groups was found with 5-HTTLPR polymorphism not significantly associated with clinical response in either ethnic group.
  
  
  CONCLUSIONS
  The results are consistent with a previous finding and in accord with most of the results obtained in Caucasian subjects that SLC6A4 genotype is not related, at least by itself, to a response to treatment in either ethnic group to any clinically significant degree.
authors.affiliation: Department of Psychiatry, Meharry Medical College, Nashville, TN, United States. rpoland@mmc.edu
authors.forename: Russell E
authors.initials: RE
authors.lastname: Poland
authors.forename: Ira M
authors.initials: IM
authors.lastname: Lesser
authors.forename: Yu-Jui Yvonne
authors.initials: YJ
authors.lastname: Wan
authors.forename: Lev
authors.initials: L
authors.lastname: Gertsik
authors.forename: Jie
authors.initials: J
authors.lastname: Yao
authors.forename: Leslie J
authors.initials: LJ
authors.lastname: Raffel
authors.forename: Keh-Ming
authors.initials: KM
authors.lastname: Lin
authors.forename: Hector F
authors.initials: HF
authors.lastname: Myers
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D044383:Black People / Q000235:genetics*; D015283:Citalopram / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000235:genetics; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D050486:Serotonin Plasma Membrane Transport Proteins / Q000235:genetics*; D044465:White People / Q000235:genetics*; D001741:Black or African American
chemical_list: D018687:Antidepressive Agents, Second-Generation; C493230:SLC6A4 protein, human; D050486:Serotonin Plasma Membrane Transport Proteins; D015283:Citalopram
references.citation: Arch Gen Psychiatry. 1961 Jun;4:561-71
references.pmid: 13688369
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2008 Oct 1;32(7):1735-9
references.pmid: 18700161
references.citation: In Vitro. 1984 Nov;20(11):856-8
references.pmid: 6519667
references.citation: Curr Psychiatry Rep. 2012 Apr;14(2):129-37
references.pmid: 22198824
references.citation: Am J Pharmacogenomics. 2003;3(2):145-7
references.pmid: 12749731
references.citation: J Pers Soc Psychol. 1993 Aug;65(2):350-9
references.pmid: 8366424
references.citation: Psychoneuroendocrinology. 1980;5(3):209-24
references.pmid: 6774361
references.citation: Depress Anxiety. 2010;27(1):56-62
references.pmid: 19960492
references.citation: Science. 1996 Nov 29;274(5292):1527-31
references.pmid: 8929413
references.citation: Eur Neuropsychopharmacol. 2012 Apr;22(4):239-58
references.pmid: 22137564
references.citation: Mol Psychiatry. 2010 May;15(5):473-500
references.pmid: 18982004
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2009 Apr 5;150B(3):341-51
references.pmid: 18618621
references.citation: Mol Psychiatry. 1998 Nov;3(6):508-11
references.pmid: 9857976
references.citation: Hum Genet. 1997 Dec;101(2):243-6
references.pmid: 9402979
references.citation: Br J Soc Clin Psychol. 1967 Dec;6(4):278-96
references.pmid: 6080235
references.citation: Psychiatr Genet. 2011 Oct;21(5):267-8
references.pmid: 21407146
references.citation: Mol Psychiatry. 2009 Dec;14(12):1105-18
references.pmid: 19844206
references.citation: Br J Psychiatry. 2011 Jun;198(6):424-7
references.pmid: 21628702
references.citation: Biol Psychiatry. 2007 Mar 15;61(6):734-42
references.pmid: 17123473
references.citation: Biol Psychiatry. 2010 Sep 15;68(6):536-43
references.pmid: 20615496